IL4 and Alzheimer disease: It was shown that blocking IL-4/IL-13 signaling, in addition to suppressing systemic Th2-type inflammation, increased microbial diversity, reducing the abundance of S. aureus, with the recovery of the altered transcriptome of epidermal proteins associated with AD.